Buy IDRA-21 10 mg Pellets – Premium Research Chemical | euro-labchems.com

Buy IDRA-21 10 mg Pellets (7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide) CAS Number: 22503-72-6 Molecular Formula: C₈H₉ClN₂O₂S Molecular Weight: 232.69 g/mol Purity: ≥98.5% (HPLC verified) Dosage per pellet: Exactly 10 mg IDRA-21 Form: Compressed pharmaceutical-grade pellets (uniform, scored for precision) Quantity options: 10, 20, 50, 100 pellets Shipping: Discreet worldwide, vacuum-sealed, moisture-proof packaging

euro-labchems.com offers high-purity IDRA-21 10 mg pellets – a potent positive allosteric modulator (PAM) of AMPA receptors, belonging to the benzothiadiazine class. Developed in the 1990s at the University of California, IDRA-21 (7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide) is one of the most studied and effective AMPAkines for enhancing glutamatergic transmission in preclinical models.

What is IDRA-21?

IDRA-21 selectively potentiates AMPA receptor-mediated currents, increasing excitatory synaptic transmission without direct agonist activity. It is widely used in neuropharmacological, cognitive, memory, neuroprotection, and synaptic plasticity research. The 10 mg pellet provides a standardized, precise research dose (typical range: 5–20 mg).

Key Product Specifications of IDRA-21 10 mg Pellets

• Pellet size: Small, consistent 3–4 mm diameter
• Excipients: Inert binders for stability & accurate dosing
• Stability: Excellent cool/dark/dry storage (2+ years)
• Potency: 10 mg per pellet – standard research dose

Research Effects & Characteristics

Duration: 8–12 hours Onset: 30–90 minutes Peak: 2–6 hours

Preclinical literature indicates strong nootropic/cognitive effects: enhanced learning & memory consolidation, increased synaptic plasticity (LTP), improved attention & information processing, neuroprotection against excitotoxicity, and mild stimulant-like wakefulness. Frequently described as one of the most potent and longest-lasting AMPAkines with minimal side effects in models.

Possible side effects (dose-dependent, research observations): mild hyperactivity/anxiety at high doses, transient headache, potential excitotoxicity risk with excessive dosing, rare tolerance with chronic use.

IDRA-21 10 mg pellets are sold strictly for scientific research – not for human/veterinary consumption. Verify local regulations. Full CoA available.

Premium IDRA-21 pellets for precise AMPA receptor research from euro-labchems.com – your trusted specialist.